Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2002
10/09/2002CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002CN1092193C Prolylendopeptidase inhibitors
10/09/2002CN1092188C Substd. aminoquinazolinone (thione) derivs. or salts thereof, intermediates thereof, and pest controller and method for using same
10/09/2002CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002US6462337 Mass spectrometer electrospray ionization
10/08/2002US6462194 2,4-disubstituted pyrrolidine-3-carboxylic acid derivatives
10/08/2002US6462074 Substituted α, β-anellated butyrolactones
10/08/2002US6462068 Heterocyclylmethyl-substituted pyrazole derivatives
10/08/2002US6462049 Low toxicity and persistent insecticides and fungicides; preventing attachment of aquatic organisms; ecosystem friendly; nonpolluting
10/08/2002US6462043 Method for producing substituted-2-nitroguanidine derivatives
10/08/2002US6462037 Such as 7-chloro-3-methyl-5-(2-cyclopropylethynyl)-1,5-dihydro-5-(trifluoromethyl) -1,4-benzodiazepin-2-one; protease inhibitors
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002CA2250243C Thiazoline acid derivatives
10/08/2002CA2066083C Benzodiazepine analogs as cholecystokinin antagonists
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076959A1 Five-membered heterocyclic alkanoic acid derivative
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076177A2 Design and synthesis of optimized ligands for ppar
10/03/2002US20020143182 For therapy of diseases having uncontrolled cellular proliferation
10/03/2002US20020143176 For therapy of diseases associdated with Factor VIIa and or inosine monophosphate dehydrogenase (IMPDH)
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143024 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/03/2002US20020142967 Thrombin inhibitors
10/03/2002US20020142290 Compound for use in the treatment of viral diseases
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002EP1246006A2 Dye-forming coupler, silver halide photographic light-sensitive material and azomethine dye compound
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244642A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1244639A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
10/02/2002EP1244631A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244627A1 Picolinic acid derivatives and their use as fungicides
10/02/2002EP1244457A2 Methods and compositions related to modulators of annexin and cartilage homeostasis
10/02/2002EP1047684B1 Substituted alpha,beta-anellated butyrolactones
10/02/2002EP0871465B1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
10/02/2002CN1372566A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/02/2002CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002CN1372552A Pyrimidine derivatives and herbicides containing the same
10/02/2002CN1372549A Fungicidies
10/02/2002CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/02/2002CN1091769C mesylate dihydrate salts of 5-(2-(4-(1,2-benzi sothiazol-2-yl)-1-piperazinyl)-ethyl)-6-chloro-1, 3-dihydro-2(1H)-indol-2-one
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/01/2002US6458959 Anti-herpesvirus compounds and methods for identifying, making and using same
10/01/2002US6458952 Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458805 Antagonists; especially sodium salts
10/01/2002US6458794 Potassium channel inhibitors
10/01/2002US6458788 4-hydroxycinnoline-3-carboxyamides as antiviral agents
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458784 Vitronectin receptor antagonists
10/01/2002US6458474 Methine compound, material for organic luminescence element, organic luminescence element using the same
10/01/2002US6457303 Wide variety of corresponding analogs and homologs.
10/01/2002CA2272719C Apo b-secretion/mtp inhibitory amides
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2089769C Heterocyclic compounds and their preparation and use
09/2002
09/27/2002CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002WO2002075318A2 Neurofibrillary labels
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
09/26/2002WO2002074042A2 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
09/26/2002WO2002074036A2 Substituted benzopyranones as telomerase inhibitors
09/26/2002WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002WO2002036116A3 Tripeptidyl peptidase inhibitors
09/26/2002WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002WO2002024636A3 N-acylsulfonamide apoptosis promoters
09/26/2002WO2001072743A1 Triazole compounds having amide linkage
09/26/2002WO2001052847A8 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
09/26/2002US20020137940 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
09/26/2002US20020137933 Heterocyclic sulfonamides
09/26/2002US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma
09/26/2002US20020137931 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002US20020137929 1 - (3-heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents
09/26/2002US20020137784 Guanidine derivatives
09/26/2002US20020137778 Anticancer, antiarthritic, and antiinflammatory agents
09/26/2002US20020137770 Piperidine derivatives
09/26/2002US20020137769 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
09/26/2002US20020137766 Electrophysiological activity
09/26/2002US20020137755 Tyrosine kinase inhibitors
09/26/2002US20020137745 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease
09/26/2002US20020137744 Metalloprotease inhibitors
09/26/2002US20020137742 Benzenesulfonamide compounds
09/26/2002US20020137740 CRF (corticotropin releasing factor) antagonists; 4-(2-Chloro-4-methoxyphenyl)-5-methyl-2-(N-(5-ethoxy-carbonyl-2 -methoxyphenyl)-N-propylamino)thiazole for example
1 ... 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 ... 628